Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor

por Liu, Yahong, Cheng, Ying, Huang, Gongchao, Xia, Xiangying, Wang, Xingkai, Tian, Hongqi
Publicado 2023

Downregulated expression of HSP27 in human low-grade glioma tissues discovered by a quantitative proteomic analysis

por Shen, Guobo, Liang, Shufang, Xu, Zhizhong, Zhou, Liangxue, Xiao, Shiyin, Xia, Xiangying, Li, Ronghui, Liao, Ying, You, Chao, Wei, Yuquan
Publicado 2010

Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma

por Xu, Zhizhong, Shen, Guobo, Xia, Xiangying, Zhao, Xinyu, Zhang, Peng, Wu, Huanhuan, Guo, Qingfa, Qian, Zhiyong, Wei, Yuquan, Liang, Shufang
Publicado 2011

PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments

por Zhang, Dan, Xia, Xiangying, Wang, Xixi, Zhang, Peng, Lu, Weiliang, Yu, Yamei, Deng, Shi, Yang, Hanshuo, Zhu, Hongxia, Xu, Ningzhi, Liang, Shufang
Publicado 2017